Homozygous mutation in SCN5A associated with atrial quiescence, recalcitrant arrhythmias, and poor capture thresholds

Heart Rhythm. 2011 Mar;8(3):471-3. doi: 10.1016/j.hrthm.2010.10.014. Epub 2010 Oct 13.

Authors

Keila N Lopez¹, Jamie A Decker, Richard A Friedman, Jeffrey J Kim

Affiliation

¹ Section of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas 77030, USA. knlopez@bcm.edu

PMID: 20950709
DOI: 10.1016/j.hrthm.2010.10.014

No abstract available

Publication types

Case Reports

MeSH terms

Amiodarone / administration & dosage
Anti-Arrhythmia Agents / administration & dosage
Arrhythmias, Cardiac / genetics*
Cardiac Pacing, Artificial
Cardiopulmonary Resuscitation
Child
Diseases in Twins / genetics*
Electrocardiography
Extracorporeal Membrane Oxygenation
Female
Heart Atria / physiopathology*
Homozygote
Humans
NAV1.5 Voltage-Gated Sodium Channel
Recurrence
Sodium Channels / genetics*
Tachycardia, Ventricular / genetics
Tachycardia, Ventricular / therapy

Substances

Anti-Arrhythmia Agents
NAV1.5 Voltage-Gated Sodium Channel
SCN5A protein, human
Sodium Channels
Amiodarone